Aristotle Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.7M Sell
130,545
-28,292
-18% -$4.94M 0.05% 123
2025
Q4
$27M Buy
158,837
+781
+0.5% +$120K 0.05% 123
2025
Q3
$20.8M Sell
158,056
-7,514
-5% -$901K 0.04% 126
2025
Q2
$17.6M Buy
165,570
+6,704
+4% +$728K 0.03% 125
2025
Q1
$19.7M Sell
158,866
-37,072
-19% -$4.84M 0.04% 119
2024
Q4
$24.1M Sell
195,938
-16,753
-8% -$1.97M 0.05% 123
2024
Q3
$23.7M Buy
212,691
+15,455
+8% +$1.69M 0.04% 123
2024
Q2
$21.1M Buy
197,236
+293
+0.1% +$32.2K 0.04% 123
2024
Q1
$23.7M Sell
196,943
-261
-0.1% -$32K 0.04% 122
2023
Q4
$24.3M Buy
197,204
+21,447
+12% +$2.68M 0.05% 118
2023
Q3
$22.7M Buy
+175,757
New +$23.4M 0.05% 116

Other funds holding JAZZ